HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 09-MAY-14 4QBX TITLE HUMAN ALDOSE REDUCTASE COMPLEXED WITH A LIGAND WITH AN IDD STRUCTURE TITLE 2 ({5-FLUORO-2-[(3-NITROBENZYL)CARBAMOYL]PHENOXY}ACETIC ACID) AT 0.98 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TIM BARREL, OXIDOREDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.RECHLIN,A.HEINE,G.KLEBE REVDAT 2 20-SEP-23 4QBX 1 REMARK REVDAT 1 22-JUL-15 4QBX 0 JRNL AUTH C.RECHLIN,F.SCHEER,P.TOTH,A.HEINE,W.DIEDERICH,G.KLEBE JRNL TITL ALDOSE REDUCTASE: HOW EXPENSIVE IS THE OPENING OF THE JRNL TITL 2 SPECIFICITY POCKET? IDD LIGANDS UNDER INVESTIGATION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 0.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 175837 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.136 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.151 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 8801 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 17.4365 - 3.0398 1.00 5688 286 0.1410 0.1594 REMARK 3 2 3.0398 - 2.4148 1.00 5622 294 0.1593 0.1795 REMARK 3 3 2.4148 - 2.1102 1.00 5601 297 0.1499 0.1666 REMARK 3 4 2.1102 - 1.9175 1.00 5574 311 0.1443 0.1710 REMARK 3 5 1.9175 - 1.7802 1.00 5597 277 0.1410 0.1518 REMARK 3 6 1.7802 - 1.6753 1.00 5583 290 0.1389 0.1441 REMARK 3 7 1.6753 - 1.5915 1.00 5542 312 0.1284 0.1447 REMARK 3 8 1.5915 - 1.5223 1.00 5555 330 0.1255 0.1372 REMARK 3 9 1.5223 - 1.4637 1.00 5577 287 0.1247 0.1352 REMARK 3 10 1.4637 - 1.4132 1.00 5546 312 0.1218 0.1354 REMARK 3 11 1.4132 - 1.3690 1.00 5573 268 0.1179 0.1433 REMARK 3 12 1.3690 - 1.3299 1.00 5631 282 0.1149 0.1262 REMARK 3 13 1.3299 - 1.2949 1.00 5560 296 0.1153 0.1395 REMARK 3 14 1.2949 - 1.2633 1.00 5544 276 0.1110 0.1237 REMARK 3 15 1.2633 - 1.2346 1.00 5554 305 0.1115 0.1310 REMARK 3 16 1.2346 - 1.2084 1.00 5548 276 0.1100 0.1228 REMARK 3 17 1.2084 - 1.1842 1.00 5556 309 0.1093 0.1407 REMARK 3 18 1.1842 - 1.1618 1.00 5589 297 0.1091 0.1196 REMARK 3 19 1.1618 - 1.1411 1.00 5547 294 0.1070 0.1257 REMARK 3 20 1.1411 - 1.1218 1.00 5521 293 0.1134 0.1270 REMARK 3 21 1.1218 - 1.1037 1.00 5563 296 0.1160 0.1288 REMARK 3 22 1.1037 - 1.0867 1.00 5577 297 0.1173 0.1342 REMARK 3 23 1.0867 - 1.0707 1.00 5563 278 0.1211 0.1388 REMARK 3 24 1.0707 - 1.0556 1.00 5525 289 0.1249 0.1447 REMARK 3 25 1.0556 - 1.0414 1.00 5615 266 0.1361 0.1364 REMARK 3 26 1.0414 - 1.0278 1.00 5484 306 0.1451 0.1424 REMARK 3 27 1.0278 - 1.0150 1.00 5587 301 0.1510 0.1639 REMARK 3 28 1.0150 - 1.0028 1.00 5544 289 0.1717 0.1868 REMARK 3 29 1.0028 - 0.9911 1.00 5526 312 0.1962 0.2184 REMARK 3 30 0.9911 - 0.9800 0.99 5544 275 0.2283 0.2478 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.070 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 12.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2738 REMARK 3 ANGLE : 1.313 3763 REMARK 3 CHIRALITY : 0.081 421 REMARK 3 PLANARITY : 0.007 482 REMARK 3 DIHEDRAL : 16.251 1015 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QBX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000085860. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : SILICON, ACTIVE SURFACE 50 NM RH REMARK 200 -COATED REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 175882 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.980 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 22.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41400 REMARK 200 FOR SHELL : 2.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2DUX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION SOLUTION: 50 MM DI REMARK 280 -AMMONIUMHYDROGEN CITRATE, PEG6000= 5 % (M/V) DTT= 5.15 G/L NADP+ REMARK 280 = 0.66 G/L AND HUMAN ALDOSE REDUCTASE= 15 MG/ML. AFTERWARDS THE REMARK 280 CRYSTALS WERE SOAKED INTO 120 MM DI-AMMONIUMHYDROGEN CITRATE PH REMARK 280 5.0 25% (M/V) PEG6000 SATURATED WITH THE INHIBITOR. THE WELL REMARK 280 SOLUTION WAS 120MM DI-AMMONIUM HYDROGEN CITRATE WITH 20% PEG6000 REMARK 280 PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.42800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 0 CG SD CE REMARK 470 LYS A 32 NZ REMARK 470 GLU A 60 CD OE1 OE2 REMARK 470 LYS A 68 NZ REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 LYS A 85 CD CE NZ REMARK 470 LYS A 116 NZ REMARK 470 LYS A 119 CD CE NZ REMARK 470 GLU A 126 CD OE1 OE2 REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 MET A 168 CE REMARK 470 LYS A 194 CG CD CE NZ REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 PRO A 222 CG CD REMARK 470 GLU A 223 CG CD OE1 OE2 REMARK 470 GLU A 229 OE1 OE2 REMARK 470 LYS A 234 CE NZ REMARK 470 GLU A 267 CD OE1 OE2 REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 ARG A 293 CD NE CZ NH1 NH2 REMARK 470 GLU A 313 CG CD OE1 OE2 REMARK 470 GLU A 314 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 -2.02 81.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30L A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1US0 RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WITH AN INHIBITOR WITH AN IDD STRUCTURE REMARK 900 RELATED ID: 4PUU RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WITH AN INHIBITOR WITH AN IDD STRUCTURE REMARK 900 RELATED ID: 4PUW RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WITH AN INHIBITOR WITH AN IDD STRUCTURE REMARK 900 RELATED ID: 4Q7B RELATED DB: PDB REMARK 900 ALDOSE REDUCTASE WITH AN INHIBITOR WITH AN IDD STRUCTURE REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS SEQUENCE CONFLICT IS ALSO ALREADY REPORTED IN THE UNIPROT REMARK 999 ENTRY P15121 DBREF 4QBX A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 4QBX ILE A 4 UNP P15121 LEU 5 SEE REMARK 999 SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET NAP A 401 48 HET 30L A 402 25 HET CIT A 403 13 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 30L {5-FLUORO-2-[(3-NITROBENZYL)CARBAMOYL]PHENOXY}ACETIC HETNAM 2 30L ACID HETNAM CIT CITRIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 30L C16 H13 F N2 O6 FORMUL 4 CIT C6 H8 O7 FORMUL 5 HOH *396(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 LYS A 100 1 17 HELIX 7 7 ASN A 136 GLU A 150 1 15 HELIX 8 8 ASN A 162 ASN A 171 1 10 HELIX 9 9 GLN A 192 LYS A 202 1 11 HELIX 10 10 SER A 226 GLU A 229 5 4 HELIX 11 11 ASP A 230 HIS A 240 1 11 HELIX 12 12 THR A 243 GLN A 254 1 12 HELIX 13 13 THR A 265 LYS A 274 1 10 HELIX 14 14 SER A 281 SER A 290 1 10 HELIX 15 15 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 LEU A 17 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 33 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 33 ASP A 43 TYR A 48 HIS A 110 TRP A 111 SITE 3 AC1 33 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC1 33 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC1 33 SER A 214 PRO A 215 ASP A 216 ALA A 245 SITE 6 AC1 33 ILE A 260 PRO A 261 LYS A 262 SER A 263 SITE 7 AC1 33 VAL A 264 THR A 265 ARG A 268 GLU A 271 SITE 8 AC1 33 ASN A 272 30L A 402 HOH A 760 HOH A 761 SITE 9 AC1 33 HOH A 777 SITE 1 AC2 10 TRP A 20 VAL A 47 TYR A 48 HIS A 110 SITE 2 AC2 10 TRP A 111 LEU A 300 CYS A 303 TYR A 309 SITE 3 AC2 10 NAP A 401 HOH A 792 SITE 1 AC3 9 GLN A 49 ASN A 50 GLU A 51 ASN A 52 SITE 2 AC3 9 GLU A 53 LYS A 94 ASP A 98 HOH A 735 SITE 3 AC3 9 HOH A 739 CRYST1 49.383 66.856 47.405 90.00 92.27 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020250 0.000000 0.000802 0.00000 SCALE2 0.000000 0.014958 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021111 0.00000